Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001470831-26-000665

Options or other derivatives

  • Director acquired 62,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Anderson Kenneth Carl · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-24 Grant or award : show line 1 in the form Stock Option (Right to Buy) +62,000 62,000 D
Loading xslF345X06/wk-form4_1782505819.xml…